Pherecydes Pharma and BIOASTER join forces to explore the use of phage therapy to treat complicated urinary tract infections
Pherecydes Pharma and BIOASTER, the French Technology Research Institute (TRI) for Microbiology and Infectious Diseases, announced the signing of a collaboration agreement. This project, called PhagUTI, is a unique opportunity for the partners to capitalize […]